API Intermediates Manufacturers in India
API Intermediates Manufacturer and Exporter in India
Shilpa Pharma is a globally recognized, world-class API Intermediates Manufacturer in India, renowned for its ability to develop and manufacture highly complex and rare api intermediates for leading pharmaceutical companies worldwide. With decades of scientific expertise and regulatory excellence, we play a critical role in enabling the production of life-saving and high-value pharmaceutical therapies across diverse therapeutic segments.
We specialize in manufacturing active pharmaceutical intermediates using advanced, proprietary processes that deliver exceptional purity, consistency, and performance. Our state-of-the-art, GMP-compliant manufacturing facilities—backed by a strong innovation-driven R&D ecosystem—enable us to produce intermediate API solutions that meet the most stringent international regulatory guidelines and evolving global market requirements.
Shilpa Pharma is uniquely positioned to handle the synthesis, optimization, and commercial scale-up of complex api and intermediates, including molecules that require advanced chemistry, controlled environments, and precise impurity management. Our integrated capabilities support the seamless manufacturing of active pharmaceutical ingredients and intermediates for highly regulated as well as semi-regulated markets, with every batch subjected to rigorous quality control, analytical validation, and regulatory-ready documentation.
As a trusted global exporter, Shilpa Pharma supplies api intermediates to pharmaceutical manufacturers across major regulated markets, ensuring uninterrupted API production and long-term supply chain reliability. Our proven regulatory track record, technical depth, and customer-centric CDMO approach make us a preferred partner for the development and manufacture of drug intermediates used in critical and complex therapies.
Driven by an uncompromising commitment to quality, innovation, and compliance, Shilpa Pharma continues to strengthen its leadership as a premier API Intermediates Manufacturer, delivering high-performance active pharmaceutical intermediates that meet approved global regulatory standards and power pharmaceutical innovation worldwide.
Offering Different Range of API Intermediates
| Peptides API Products Available | |
|---|---|
| S. No. | Product Name |
| 1 | Desmopressin Acetate |
| 2 | Liraglutide |
| 3 | Octreotide Acetate |
| 4 | Semaglutide |
| 5 | Teripartide |
| api intermediates Products Available | |||
|---|---|---|---|
| Sr. No. | Product Name | CAS No. | Mol. Weight |
| 1 | 3-Hydroxy Acetophenone (Phenylephrine Hydrochloride KSM-I) |
121-71-1 | 1129.27 g/mol |
| 2 | ((1S,4R)-4-aminocyclopent-2-en-1-yl)methanol (2S,3S)-2,3-dihydroxysuccinate (Abacavir Sulfate KSM-II)229177-52-0 | 229177-52-0 | 263.24 |
| 3 | 3. 4-isothiocyanato-2-(trifluoromethyl)benzonitrile (Enzalutamide KSM-III) |
143782-23-4 | 228.19 g/mol |
| 4 | S-2-Aminobutanamide hydrochloride (Levetiracetam KSM-I) |
7682-20-4 | 136.80 g/mol |
Request a Quote for Drug Intermediates Today
GMP-compliant drug intermediates with consistent batch quality
Reliable API intermediates supply for global pharmaceutical markets
Custom intermediate API solutions with scalable manufacturing
Our Expertise at a Glance
Leading the Way in Pharma Innovation
1987
Established
100+
R&D workforce
1500+
Team size
3
Manufacturing site
100+
Audits
500+
Customers
100+
Projects
Shilpa Pharma’s Portfolio of Drug API Pharmaceutical Manufacturing
Shilpa Pharma offers a robust and diversified portfolio of drug API pharmaceutical manufacturing and CDMO services, supported by deep expertise in api intermediates, api and intermediates, and advanced process development. Our integrated CDMO and manufacturing capabilities enable the reliable production of active pharmaceutical ingredients and intermediates that meet stringent global quality and regulatory standards.
Our portfolio includes a wide range of intermediate API solutions and active pharmaceutical intermediates designed to support efficient API synthesis across multiple therapeutic categories. As a trusted CDMO partner, we support pharmaceutical companies from early-stage development to commercial-scale manufacturing, ensuring consistency, scalability, and compliance at every stage of production.
As a globally recognized API Intermediates Manufacturer, Shilpa Pharma specializes in producing high-purity drug intermediates that play a critical role in downstream API formulation. Our GMP-compliant facilities, supported by advanced analytical systems, ensure stringent quality control, batch-to-batch reproducibility, and regulatory-ready documentation for regulated and semi-regulated markets.
Shilpa Pharma’s end-to-end CDMO approach to api and intermediates manufacturing enables us to deliver customized solutions, process optimization, and reliable supply continuity. Backed by a strong R&D foundation and technical expertise, we develop complex active pharmaceutical intermediates aligned with evolving global market requirements.
With a focus on quality, innovation, and regulatory excellence, Shilpa Pharma continues to expand its drug API pharmaceutical manufacturing and CDMO portfolio, supplying trusted api intermediates and high-performance solutions to pharmaceutical partners across Japan, China, the United States, Russia, and other global markets.
Serving Clients Across The Globe
Learn More About Active Pharmaceutical Ingredients Intermediate Drugs
API Intermediates Manufacturer in India – Shilpa Pharma
India has emerged as a global hub for the manufacturing of api intermediates, supporting pharmaceutical companies with cost-effective, high-quality, and scalable solutions. As a trusted API Intermediates Manufacturer, Shilpa Pharma plays a critical role in strengthening global pharmaceutical supply chains through reliable production of drug intermediates.
Shilpa Pharma specializes in the development and manufacturing of api and intermediates that are essential for the synthesis of finished APIs. Backed by advanced process chemistry, GMP-compliant facilities, and strong regulatory expertise, we support pharmaceutical companies across regulated and semi-regulated markets worldwide.
What Are API Intermediates?
API intermediates are chemical compounds produced during the multi-step synthesis of an Active Pharmaceutical Ingredient (API). These intermediate API substances act as building blocks that undergo further chemical transformation to become final drug APIs.
In simple terms, active pharmaceutical intermediates sit between raw materials and finished APIs, making them a vital part of pharmaceutical manufacturing. The quality, purity, and consistency of these intermediates directly impact the safety and efficacy of the final drug product.
Difference Between API and API Intermediates
While APIs are the active components responsible for the therapeutic effect of a medicine, api intermediates are precursor compounds used during API synthesis. Unlike APIs, intermediates are not administered directly to patients but are critical for achieving the desired chemical structure and quality of the final API.
A reliable API Intermediates Manufacturer ensures that every intermediate meets defined specifications, enabling smooth downstream processing and regulatory compliance for finished APIs.
API Intermediates Manufacturing at Shilpa Pharma
Shilpa Pharma manufactures a wide range of drug intermediates and active pharmaceutical intermediates using advanced synthetic chemistry and process optimization techniques. Our capabilities cover early-stage development, process scale-up, and commercial manufacturing.
With a strong focus on quality-by-design (QbD), our api and intermediates manufacturing processes ensure batch-to-batch consistency, impurity control, and reproducibility. This enables our partners to achieve efficient API synthesis and faster regulatory approvals.
What to Know When Sourcing API Intermediates
When sourcing api intermediates, pharmaceutical companies should consider process robustness, impurity profiles, scalability, and regulatory documentation. Selecting an experienced API Intermediates Manufacturer helps reduce supply chain risks and ensures long-term manufacturing continuity.
Shilpa Pharma provides complete technical support, including specifications, analytical methods, stability data, and regulatory-ready documentation for active pharmaceutical ingredients and intermediates.
Global Regulatory Standards and Compliance
As a globally trusted manufacturer of api intermediates, Shilpa Pharma operates facilities that comply with stringent international quality and regulatory standards. Our manufacturing systems are designed to support global filings and inspections.
Our facilities adhere to:
- USFDA compliance standards
- EU GMP guidelines
- PMDA (Japan)
- WHO-GMP requirements
These standards allow us to supply drug intermediates to pharmaceutical companies across regulated and emerging markets.
Why Choose Shilpa as Your API Intermediates Partner?
- Proven expertise as an API Intermediates Manufacturer
- Strong portfolio of api intermediates and intermediate API
- GMP-compliant manufacturing and regulatory support
- Scalable production for active pharmaceutical intermediates
- Reliable global supply of active pharmaceutical ingredients and intermediates